SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000947871-24-000767
Filing Date
2024-09-23
Accepted
2024-09-23 16:34:22
Documents
2
Group Members
ORBIMED CAPITAL GP VII LLCORBIMED GENESIS GP LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ss3895786_sc13d.htm SC 13D 109194
2 JOINT FILING AGREEMENT ss3895786_ex9901.htm EX-99.1 6665
  Complete submission text file 0000947871-24-000767.txt   117463
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D

Mailing Address 12406 HORESHAM STREET CARMEL IN 46032
Business Address 12406 HORESHAM STREET CARMEL IN 46032 3179893100
MBX Biosciences, Inc. (Subject) CIK: 0001776111 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-94623 | Film No.: 241316606
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)